GC32007
Btk inhibitor 2
Also known as 5-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazole-4-carboxamide
Btk inhibitor 2 (BGB-3111 analog) is a Bruton's tyrosine kinase (BTK) inhibitor extracted from patent US 20170224688 A1
ChemicalCAS1558036-85-3MW431.49FormulaC24H25N5O3
- CAS number
- 1558036-85-3
- Molecular weight
- 431.49
- Formula
- C24H25N5O3
- Solubility
- DMSO ： 75 mg/mL (173·82 mM)
- InChIKey
- WTLRSSATGYETCG-QGZVFWFLSA-N
- Catalogue number
- GC32007
- Brand
- GLPBIO
Computed properties PubChem CID 75204377 · XLogP 3 · TPSA 116 Ų · H-bond donors 2
- XLogP
- 3
- TPSA
- 116 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 6
- Heavy atoms
- 32
SMILES C=CC(=O)N1CCC[C@H](C1)N2C(=C(C(=N2)C3=CC=C(C=C3)OC4=CC=CC=C4)C(=O)N)N
Computed descriptors from PubChem (CID 75204377), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il